Eledon Presents Phase 2 BESTOW Trial Results for Tegoprubart for the Prevention of Rejection in Kidney Transplantation at the American Society of Nephrology's Kidney Week 2025 Annual Meeting GlobeNewswire November 06, 2025 Data from patients who remained on tegoprubart for a year post transplant showed an overall mean 12-month estimated glomerular filtration rate (eGFR) of […]

Vafseo(R) (vadadustat) Dialysis Dependent Patient Post Hoc Data Analysis: Composite of All-Cause Mortality and Hospitalization Outcomes Statistically More Favorable for Patients Receiving Vadadustat vs. ESAs Win-Odds Analysis Presented at American Society of Nephrology Kidney Week 2025 GlobeNewswire November 06, 2025 CAMBRIDGE, Mass., Nov. 06, 2025 (GLOBE NEWSWIRE) — Akebia Therapeutics(R), Inc. (Nasdaq: AKBA), a biopharmaceutical

A new class action complaint has been filed against aTyr Pharma, Inc. (NASDAQ: ATYR) and certain of its top executives, significantly enlarging the alleged class period covered by the ongoing securities litigation. https://mma.prnewswire.com/media/2590203/Hagens_Berman_Sobol_Shapiro_LLP_Logo.jpg The new class action, King v. aTyr Pharma Inc., filed in the U.S. District Court for the Southern District of California on

(NasdaqGM:ALVO), NEW YORK, Nov. 06, 2025 (GLOBE NEWSWIRE) — Scott+Scott Attorneys at Law LLP (“Scott+Scott”), a shareholder and consumer rights litigation firm, is investigating whether Alvotech (the “Company”) (NASDAQ: ALVO) or certain of its officers and directors issued misleading and false statements and/or failed to disclose information material to investors in violation of federal securities

Scott+Scott Attorneys at Law LLP Alerts Investors of Its Investigation into Alvotech (NASDAQ: ALVO) GlobeNewswire November 06, 2025 NEW YORK, Nov. 06, 2025 (GLOBE NEWSWIRE) — Scott+Scott Attorneys at Law LLP (“Scott+Scott”), a shareholder and consumer rights litigation firm, is investigating whether Alvotech (the “Company”) (NASDAQ: ALVO) or certain of its officers and directors issued

JHX Investors with Losses Encouraged to Contact the Firm A class-action lawsuit has been filed against James Hardie Industries plc (NYSE: JHX), the dominant producer of fiber cement building materials in the U.S., alleging the company committed securities fraud by misleading investors about inventory levels and customer demand in its crucial North American segment. https://mma.prnewswire.com/media/2590203/Hagens_Berman_Sobol_Shapiro_LLP_Logo.jpg

A securities fraud class action, styled Kim v. Synopsys, Inc., et al., No. 26-:cv-09410 (N.D. Cal.) has been filed and seeks to represent investors who purchased or otherwise acquiredSynopsys, Inc. (NASDAQ: SNPS) securities between December 4, 2024 and September 9, 2025. https://mma.prnewswire.com/media/2590203/Hagens_Berman_Sobol_Shapiro_LLP_Logo.jpg The lawsuit was filed after Synopsys announced disappointing Q3 2025 financial results, blaming

(NASDAQ:SWVL), DUBAI, United Arab Emirates, Nov. 06, 2025 (GLOBE NEWSWIRE) — Swvl Holdings Corp (“Swvl” or the “Company”) (Nasdaq: SWVL), a global provider of tech-enabled mobility solutions, today announced that on October 31, 2025, it received written notice (the “Notice”) from The Nasdaq Stock Market (“Nasdaq”) advising the Company that it was not in compliance

Swvl Received Nasdaq Notification Regarding Minimum Market Value Deficiency GlobeNewswire November 06, 2025 DUBAI, United Arab Emirates, Nov. 06, 2025 (GLOBE NEWSWIRE) — Swvl Holdings Corp (“Swvl” or the “Company”) (Nasdaq: SWVL), a global provider of tech-enabled mobility solutions, today announced that on October 31, 2025, it received written notice (the “Notice”) from The Nasdaq

Photo courtesy of Pravo Ventures WASHINGTON, Nov. 06, 2025 (GLOBE NEWSWIRE) — A new U.S. platform is opening a secure, regulated pathway for accredited investors to participate in Ukraine's fast-evolving defense and deep-tech economy–with investments starting at just $2,500. Pravo Ventures, a Washington-based syndicate, connects American investors with Ukrainian startups that develop defense, dual-use, and